Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Monday, May 4, 2026

Snapshot: May 4, 2026 · 6:00 PM 100 stocks analyzed

Down Day

Mon, May 4, 2026 Broad Selloff High

Broad selloff gripped equities as small caps plunged 60bps ahead of Russell, tech stumbled, and VIX spiked 7.65%, though high-conviction individual trades created pockets of 500…

60% Small caps led the rout, with Russell 2000 down 0.60% versus S&P 500's 0.40% decline, signaling a sharp rotation out of beaten-down names into safety; VIX jumped 7.65% reflecting a tactical fear spike despite modest headline moves.
25% Extreme dispersion dominated the tape: 50 gainers averaged +43.5% (SKK explosive +597% on drone deal, CNSP +239% on financing) while 50 losers averaged -23.9%, including XNDU's -61% SPAC dilution crash, creating a bifurcated market punishing leverage and rewarding M&A surprise catalysts.
15% Three stocks (SDOT, CREG, RDAC) extended three-day losing streaks despite broad volatility, while five debutant gainers—SKK, CNSP, GBTG, CRE, RLYB—returned after long absences, pointing to sector-specific deal activity and clinical/regulatory breakthroughs offsetting macro headwinds.

Worst avg loser % YTD (-23.9%) 5 names returned after long absences SDOT · 3-day losers streak CREG · 3-day losers streak SKK — first appearance CNSP — first appearance

Market Regime

Mon, May 4, 2026 Risk-On conf: high macro · prototype

+32

Tailwind −100 … +100 · + tailwind / − headwind

VIX18.3 p63 Drawdown-0.4% Held16d · extended SinceApr 13

Top drivers: S&P 20d return ▲ S&P vs 50d avg ▲ S&P vs 20d avg ▲

processId: history-market-regime

Market Indexes

Mon, May 4, 2026 4

S&P 500

7,201.32

−28.80

-0.40%

NASDAQ Composite

25,067.80

−46.64

-0.19%

Russell 2000

2,796.00

−16.83

-0.60%

VIX

18.29

+1.30

+7.65%

Biggest Gainers

Mon, May 4, 2026 50

SKK

SKK Holdings LimitedIndustrials

$12.19+$10.44

+596.5%

NASDAQ · Mkt cap $14 M

SKK Holdings announced a definitive asset purchase agreement to acquire drone assets from Rantizo, Inc. for approximately $258.8 million, establishing itself as a publicly-traded operator of commercial drone platforms, which triggered the explosive +596.53% single-day gain.

The headline establishes that SKK Holdings signed a definitive agreement on May 4, 2026 to acquire drone-based commercial platform assets from Rantizo, Inc. for roughly $258.8 million. This is a material corporate development—a significant asset acquisition that fundamentally repositions the company's business toward a high-growth, commercially-applied drone sector. The market's extreme reaction (+596.53%, ranking it 1 gainer on NASDAQ that day) suggests either the stock was severely undervalued or thinly traded before the announcement, or the market views this strategic pivot as transformational. The timing of the announcement coinciding precisely with the price spike confirms this news is the direct catalyst. No conflicting information or alternative catalysts appear in the provided headlines.

CNSP

CNS Pharmaceuticals, Inc.Healthcare

$7.84+$5.53

+239.4%

NASDAQ · Mkt cap $8.5 M

CNS Pharmaceuticals announced an oversubscribed $22.5 million private placement financing backed by leading healthcare investors, likely triggering the 239% surge as a sign of strong institutional confidence and capital runway extension.

The headline explicitly reports that CNS Pharmaceuticals secured a $22.5 million private placement that was oversubscribed, meaning demand exceeded supply. The financing included participation from respected healthcare-focused investors including ADAR1 Capital, Ikarian Capital, Stonepine Capital Management, and Nazare Partners. The announcement states proceeds are expected to enable CNS to advance its operations. For a small-cap biotech stock, an oversubscribed financing round signals institutional validation and typically resolves near-term cash concerns, both of which are major positive catalysts. A 239% move is dramatic but not unprecedented for micro-cap or financially stressed biotech firms receiving fresh capital injections, particularly when the financing is oversubscribed, indicating strong demand and investor conviction in the company's pipeline or strategy.

Skycorp Solar Group LimitedEnergy

$5.42+$2.56

+89.2%

NASDAQ · Mkt cap $5.4 M

Skycorp Solar announced a $20.2 million acquisition of the remaining 56% stake in Nanjing Cesun plus a $3 million PIPE raise, driving the 89% single-day jump as the third-largest gainer on NASDAQ.

The news headline explicitly states that Skycorp soared over 125% on the Nanjing Cesun deal announcement, which is slightly higher than the reported 89% move at snapshot time on 2026-05-04. The acquisition of a controlling stake in a subsidiary combined with fresh capital injection through a PIPE (private investment in public equity) transaction typically signals management confidence in growth prospects and reduces financial constraints. For a small-cap solar company, completing a major subsidiary acquisition while raising new funding can be viewed as materially accretive to shareholder value, justifying a sharp single-day rally. The magnitude of the move aligns directly with the materiality of the transaction relative to what appears to be a micro-cap or small-cap equity base.

JLHL

Julong Holding Limited Class A Ordinary SharesIndustrials

$19.79+$8.34

+72.8%

NASDAQ · Mkt cap $152 M

No news headlines were found in the last 48 hours, so the 72.84% gain cannot be directly attributed to a disclosed catalyst. The jump likely reflects a technical rebound, short covering, or an unannounced corporate event not yet captured in public feeds.

The absence of recent news headlines for JLHL makes it impossible to establish a specific fundamental trigger for this dramatic one-day gain. A 72.84% jump is significant enough to suggest either a material company announcement (earnings beat, strategic partnership, delisting reversal, or insider transaction) that has not yet propagated through the Yahoo Finance RSS feed, or a technical/sentiment-driven move such as short covering in a thinly traded stock, a delayed market reaction to an earlier announcement, or algorithm-driven volatility. Given that JLHL trades on NASDAQ, it is also worth noting that smaller or Chinese-linked ADRs can experience outsized single-day moves on minimal volume or sentiment shifts unrelated to disclosed news.

GBTG

Global Business Travel Group, Inc.Consumer Cyclical

$9.34+$3.41

+57.5%

NYSE · Mkt cap $5.0 B

Global Business Travel Group announced a $6.3 billion take-private deal by Long Lake on May 4, 2026, alongside a Q1 earnings beat, triggering the 57.5% surge as the deal price represents a significant premium to the prior market valuation.

The headlines establish that on May 4, 2026, GBTG announced a definitive acquisition agreement to be taken private by Long Lake at $6.3 billion in cash, with support from General Catalyst and Alpha Wave. The same day, the company reported Q1 2026 earnings that beat consensus by 11.11% on earnings per share and 4.18% on revenue. For a publicly traded company, announcement of a take-private deal at a fixed cash price substantially above the pre-announcement stock price is the canonical catalyst for a single-day gain of this magnitude. The earnings beat reinforces the narrative that the business is performing well, which may have influenced the buyer's valuation or simply stacked positive sentiment. The 57.5% move is consistent with the gap between the prior market price and the acquisition price implied by the deal terms.

CRE

Cre8 Enterprise Limited Class A Ordinary SharesIndustrials

$3.67+$1.26

+52.3%

NASDAQ · Mkt cap $5.2 M

No news headlines were found in the last 48 hours, so the 52% gain on May 4, 2026 likely stems from a delayed announcement, technical/short squeeze activity, or an intraday catalyst not yet indexed by Yahoo Finance RSS.

The absence of any recent headlines despite a massive 52% single-day move is notable and suggests either a lag in news dissemination, a company-specific catalyst that happened intraday without immediate press coverage, or market-driven technical factors. For a small-cap equity like Cre8 Enterprise, possible explanations include a delayed earnings release, insider announcement, regulatory approval, or partnership news that may not have been picked up in the RSS feed lag. Alternatively, the move could reflect short-covering or retail momentum if the stock has historically been held by speculative traders. Without verified news, attribution remains speculative; the most prudent statement is that the headline pipeline does not currently explain the move.

HCAI

Hauchen AI Parking Management Technology Holding Co., Ltd.Industrials

$18.20+$6.18

+51.4%

NASDAQ · Mkt cap $7.9 M

No news headlines were found in the last 48 hours, so the 51.41% surge in HCAI stock on May 4, 2026 cannot be directly attributed to a specific announced event based on available evidence.

The complete absence of recent news headlines makes it impossible to pinpoint a concrete catalyst for this sharp move. HCAI is a small-cap Chinese parking management technology company trading on NASDAQ, a category that can be sensitive to several forces: delayed news dissemination on Western financial platforms for non-U.S. firms, technical trading activity or short-covering in low-volume stocks, social media-driven retail interest, or announcements made on Chinese platforms that have not yet propagated to mainstream U.S. financial feeds. The 51.41% single-day jump is dramatic enough to suggest either a significant corporate event (earnings beat, strategic partnership, or guidance raise) or elevated retail/technical activity, but without corroborating headlines, either explanation remains speculative. It is also possible that news will appear later in the trading day or in subsequent financial reporting.

RLYB

Rallybio CorporationHealthcare

$14.12+$4.71

+50.1%

NASDAQ · Mkt cap $90 M

No news headlines were found in the last 48 hours, so the 50% gain on May 4th likely stems from a clinical trial result, regulatory decision, partnership announcement, or market rumor not yet captured in the RSS feed.

Rallybio is a clinical-stage biopharmaceutical company, and a 50% single-day jump without accompanying news in the provided headlines suggests the catalyst either arrived outside the tracked RSS window, emerged from social media or press release channels not yet indexed, or reflects delayed market reaction to an earlier announcement. For early-stage biotech stocks like RLYB, typical drivers of such moves include positive Phase 2 or Phase 3 trial data, FDA breakthrough designation or other regulatory milestones, strategic partnerships or licensing deals, funding announcements, or clinical program expansions. The magnitude of the gain is consistent with a meaningful clinical or regulatory event rather than routine business news. Without the actual headline, however, any specific attribution remains speculation based on sector norms.

CRCG

Leverage Shares 2x Long CRCL Daily ETF

$3.83+$1.08

+39.3%

NASDAQ

No news headlines were published in the last 48 hours, but CRCG is a 2x leveraged long ETF tracking CRCL, so a sharp gain likely reflects a strong move in the underlying security amplified by the 2x daily reset mechanism.

The absence of news headlines in the last 48 hours means we cannot identify a specific corporate or market event driving the move. However, CRCG's structure as a daily leveraged ETF provides a mechanical explanation: it uses 2x leverage to track CRCL's daily returns, so a roughly 19.6% gain in CRCL would produce approximately the 39.27% gain observed in CRCG. The spike in CRCL itself could stem from several sources typical for small-cap or micro-cap securities—company-specific news not yet indexed in the RSS feed, options-driven buying, short covering, sector momentum, or delayed earnings disclosure. Without access to CRCL-specific news or technical charts, we cannot determine which factor is operative. The leverage mechanism is confirmed; the underlying catalyst is not.

BNCWZ

CEA Industries Inc.

$0.53+$0.14

+34.6%

NASDAQ

No news was published in the last 48 hours for BNCWZ, so the 34.62% gain cannot be attributed to a specific announced catalyst. The move is likely driven by technical factors, low liquidity, or market rumors not yet captured in financial news feeds.

The absence of recent headlines is notable for a stock that ranked as the tenth biggest gainer on the day. BNCWZ appears to be a micro-cap security (trading at $0.53), and such stocks are often highly susceptible to price swings driven by factors other than fundamental news: thin trading volume can amplify small buy orders into large percentage moves, short covering or retail momentum plays can drive rapid rallies without accompanying press releases, and delayed news propagation in low-volume stocks means catalysts may exist but not yet appear in major RSS feeds. It is also possible that news was released through a channel not indexed by Yahoo Finance, or that the move reflects resolution of previously known uncertainty rather than a new announcement.

ABVE

Above Food Ingredients Inc. Common StockConsumer Defensive

$0.71+$0.18

+33.3%

NASDAQ · Mkt cap $4.9 M

No news headlines were found in the last 48 hours, so the 33% gain on May 4th likely reflects a technical bounce, delayed market reaction to an older announcement, or speculative trading activity in this micro-cap stock.

Above Food Ingredients is a small-cap food ingredient supplier trading at $0.71, and a 33% single-day jump with zero associated headlines in the past two days is not uncommon for stocks in this market segment. The absence of news does not rule out a catalyst—the announcement triggering the move may have come more than 48 hours prior, or the gain may be driven by technical factors such as short covering, options expiration dynamics, or retail-driven momentum in a thinly traded security. Micro-cap food ingredient stocks can be volatile and may respond to sector tailwinds, supply chain developments, or customer wins that circulate through channels other than major news wires. Without a headline anchor, pinpointing the specific cause is speculative.

DARE

Daré Bioscience, Inc.Healthcare

$3.11+$0.77

+32.9%

NASDAQ · Mkt cap $16 M

No news headlines were found in the last 48 hours, so the 32.91% gain likely reflects a delayed market reaction to an earlier announcement, a technical/short-squeeze event, or intraday momentum in the biotech sector.

Despite a significant one-day rally ranking DARE in the top 12 gainers on NASDAQ, no recent news headlines are available to explain the move directly. For a biotech company of this size, catalysts typically include clinical trial results, FDA decisions, partnership announcements, or financing news. The absence of headlines in the 48-hour window suggests either the catalyst preceded that period, the market is reacting to broader sector trends affecting small-cap biotech, or the move reflects technical factors such as short covering or algorithmic trading. Without confirmed news, any specific explanation remains speculative. The stock's previous price action and short interest levels would help clarify whether this is a fundamental revaluation or a technical event, but that data is not provided here.

CLNN

Clene Inc.Consumer Defensive

$8.09+$1.95

+31.8%

NASDAQ · Mkt cap $54 M

Clene received FDA acknowledgment that its CNM-Au8 ALS drug candidate's neurofilament light biomarker data may support an accelerated approval NDA submission, triggering a 31.76% gain on positive regulatory momentum.

On May 4, 2026, Clene announced successful completion of an FDA meeting in which the agency stated that proposed neurofilament light biomarker data for CNM-Au8 may be capable of supporting submission and review under the accelerated approval pathway for ALS treatment. Accelerated approval pathways are significant de-risking events for biotech stocks because they indicate regulatory flexibility and potentially faster time to market, reducing clinical trial burden. This is a concrete, binary catalyst: the FDA's green light on the biomarker endpoint and accelerated pathway is exactly the type of regulatory milestone that drives sharp single-day moves in development-stage biotech companies. The stock's rank as the 13th biggest gainer suggests broad-based recognition of the news' importance. No negative news appears in the provided headlines.

SGMO

Sangamo Therapeutics, Inc.Healthcare

$0.18+$0.04

+31.6%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 31.56% gain cannot be attributed to a specific public announcement. The move likely reflects technical trading, short-covering, or untracked developments in this small-cap biotech stock.

Sangamo is a small-cap gene-editing and gene therapy company, the type of stock that can experience large percentage swings on modest absolute volume, especially when trading at a depressed price level like $0.18. With zero headlines in the most recent 48-hour window, the catalyst is not immediately identifiable from public news sources. Possible explanations include short-squeeze activity (common in microcap biotech), technical mean-reversion after a sustained decline, insider buying signals, or delayed publication of a clinical update or partnership announcement not yet indexed by the RSS feed monitored. Without corroborating headlines or company filings, we cannot pinpoint the specific event that triggered the jump.

CHAI

Core AI HoldingsCommunication Services

$1.40+$0.34

+31.5%

NASDAQ · Mkt cap $6.8 M

No news headlines were found in the last 48 hours, so the 31.46% jump in CHAI stock cannot be directly attributed to a reported corporate announcement or market event based on available evidence.

The absence of any news in the Yahoo Finance RSS feed for CHAI over the last 48 hours means we cannot anchor the move to a specific catalyst like earnings, product announcements, partnerships, or guidance changes. For a micro-cap AI-focused stock trading at $1.40, price movements of this magnitude can be driven by several categories of events: technical factors such as short-squeeze activity or unusual options positioning, delayed or embargoed news not yet reflected in major feeds, social media momentum in retail trading communities, sector rotation into AI names, or broker upgrades that may not yet be widely syndicated. Without corroborating headlines, any specific explanation would be speculation. The stock's rank as the 15th biggest gainer suggests broad market visibility but does not clarify causation.

CABA

Cabaletta Bio, Inc.Healthcare

$3.83+$0.89

+30.3%

NASDAQ · Mkt cap $589 M

Cabaletta Bio announced a $150 million underwritten offering on May 4, 2026, which likely triggered the 30% single-day gain, though offering announcements typically pressure stock prices rather than boost them, suggesting positive sentiment or a concurrent clinical catalyst not fully captured in …

The headline confirms Cabaletta announced a $150 million underwritten public offering on the morning of May 4, 2026. Typically, capital raises dilute existing shareholders and often cause sell-offs rather than rallies. The 30% jump is therefore unusual and suggests either: (1) the offering was priced substantially above market expectations, signaling confidence in valuation; (2) investors interpreted the capital raise as enabling near-term clinical or commercial progress in the company's targeted cell therapy pipeline; or (3) a positive clinical or regulatory development occurred alongside the offering but is not detailed in the truncated headline provided. Without the full press release or concurrent news, the exact mechanism driving the rally cannot be confirmed from the evidence at hand.

WYY

WidePoint CorporationTechnology

$8.85+$1.99

+29.0%

AMEX · Mkt cap $91 M

No news headlines were published in the last 48 hours, so the 29% jump on May 4 cannot be directly attributed to a disclosed event. The move likely stems from technical factors, market rumors, or delayed reporting of company announcements not yet captured in the news feed.

WidePoint Corporation (WYY) surged 29% with no corresponding news headlines in the Yahoo Finance RSS feed over the preceding two days. This disconnect suggests either a significant intraday catalyst that has not yet been widely reported, a technical or sentiment-driven move in a thinly traded small-cap security, or a delayed dissemination lag between company announcements and major news aggregators. WYY operates in cybersecurity and identity management, sectors prone to contract wins or government funding announcements that can move smaller-cap stocks sharply. Additionally, low-liquidity small-cap stocks on regional exchanges like AMEX can experience outsized moves on moderate volume, short covering, or retail trading activity. Without corroborating headlines, pinpointing the catalyst is speculative.

NBIG

Leverage Shares 2x Long NBIS Daily ETF

$19.46+$4.35

+28.8%

NASDAQ

No news headlines available in the last 48 hours, but NBIG's +28.79% surge likely reflects a sharp gain in its underlying index (NBIS) amplified by the 2x daily leverage structure of the ETF.

NBIG is a 2x leveraged daily ETF tracking the NBIS index, meaning it amplifies daily moves of the underlying by a factor of two. With no news published in the past 48 hours, the move appears to stem from price action in NBIS itself rather than a discrete corporate or market event affecting NBIG directly. A +28.79% jump in a 2x leveraged instrument is consistent with roughly a +14% move in the underlying index. Without access to NBIS component news or broader market catalysts on May 4, 2026, we cannot identify the specific driver. Possible causes include sector rotation, technical momentum, index rebalancing, or delayed disclosure of underlying constituent news, but these remain inference rather than established fact.

NBIL

GraniteShares 2x Long NBIS Daily ETF

$27.73+$6.13

+28.4%

NASDAQ

No headlines found in the last 48 hours to explain the 28.38% surge, but NBIL is a 2x leveraged ETF that amplifies daily moves in its underlying NBIS index, so a strong rally in that index would mechanically produce roughly double the gain.

Zero news headlines were available in the provided 48-hour window, so no specific corporate event, earnings beat, or market catalyst can be identified from the record. However, NBIL's structure as a 2x long daily ETF means its price action is mechanically tied to the underlying NBIS index with leverage. A roughly 14% intraday move in NBIS would produce a 28% move in NBIL before fees and tracking slippage. This means the gain is almost certainly driven by a sharp rally in the underlying index itself, not by any news specific to NBIL. Without visibility into what moved NBIS, the ultimate cause remains opaque, but the mechanism is clear: leverage amplification of the underlying asset's daily performance.

MNDR

Mobile-health Network Solutions Class A Ordinary SharesHealthcare

$1.20+$0.25

+26.3%

NASDAQ · Mkt cap $2.0 M

Mobile-health Network Solutions announced a non-binding US$119 million strategic framework with Hector Capital to acquire BIMA and M&M Helix, accelerating AI-powered healthcare expansion across Asia and Africa, which likely triggered the 26% gain.

The company disclosed a material acquisition agreement involving significant assets (BIMA and M&M Helix) valued at $119 million, paired with expansion into two large emerging markets (Asia and Africa) where digital health adoption is accelerating. For a micro-cap health-tech stock trading at $1.20, this represents substantial growth ambition and validates the AI-powered healthcare platform thesis. The non-binding nature of the framework introduces execution risk, but the announcement of named acquirer partners and specific deal structure is concrete enough to drive speculative upside, particularly in a sector where digital health solutions have seen renewed investor interest post-pandemic.

IMDX

Insight Molecular Diagnostics Inc.Healthcare

$5.23+$1.05

+25.1%

NASDAQ · Mkt cap $143 M

No news headlines were reported in the last 48 hours for IMDX, so the 25% jump on May 4, 2026 cannot be attributed to a confirmed public announcement. The move likely reflects technical trading, delayed news dissemination, or unconfirmed market rumors.

The absence of any Yahoo Finance headlines in the 48-hour window preceding this significant gain is notable. For a diagnostic company like Insight Molecular Diagnostics, typical catalysts that drive large single-day moves include clinical trial results, FDA approvals or clearances, partnership announcements, earnings surprises, or guidance revisions. Without confirmed news in the provided sources, this gain could reflect several possibilities: a delayed or embargoed announcement not yet indexed by the RSS feed, short-covering in a thinly traded stock, technical momentum following a prior day's accumulation, insider activity ahead of an unannounced event, or market chatter and rumors that have not yet materialized into official corporate disclosure. Biotech and diagnostics stocks are particularly susceptible to pre-announcement runs based on incomplete information.

HCICR

Hennessy Capital Investment Corp. VIII Share Rights

$0.20+$0.04

+24.9%

NASDAQ

No news headlines were reported in the last 48 hours for HCICR, so the 25% gain likely reflects either technical trading activity in a low-float micro-cap security or an unreported corporate event tied to the SPAC's merger timeline or shareholder actions.

HCICR is a share rights offering tied to Hennessy Capital Investment Corp. VIII, a special purpose acquisition company (SPAC). The stock's structure makes it sensitive to redemption dynamics, merger timelines, and technical moves in micro-cap securities with thin trading volumes. Without news headlines to anchor the move, several inference-based categories fit: (1) delayed market pricing of a previously announced SPAC merger milestone or extension vote, (2) short-covering in a thinly-traded security where a small volume spike drives outsized percentage gains, (3) retail or algorithmic buying triggered by technical levels or momentum screening, or (4) an unreported corporate announcement or shareholder communication not yet reflected in major news feeds. SPAC rights and warrants often exhibit sharp intraday moves on light volume disconnected from contemporaneous headlines.

CCM

Concord Medical Services Holdings LimitedHealthcare

$4.90+$0.95

+24.0%

NYSE · Mkt cap $21 M

The headline provided only mentions that Asian equities traded as ADRs opened the week higher on Monday, offering no specific news about Concord Medical itself. The 24% jump likely reflects broad Asian ADR strength or a company-specific catalyst not captured in the available headlines.

The single headline in the news feed is generic and describes only that Asian ADRs as a sector opened higher on Monday, without any mention of Concord Medical specifically or any company-level catalyst. CCM is a healthcare services provider with ADR status, so it would benefit from broad ADR strength, but a 24% intraday gain suggests either a significant sector or company-specific event. Possible drivers could include favorable earnings or guidance not yet published in the headline feed, a clinical trial result, a partnership announcement, insider buying, short covering, or technical momentum in a thinly traded security. Without more detailed news, the precise cause remains unclear.

KMRK

K-Tech Solutions Company LimitedConsumer Cyclical

$2.80+$0.54

+23.9%

NASDAQ · Mkt cap $24 M

No news headlines were published in the last 48 hours for KMRK, so the 23.89% gain likely reflects either delayed market reaction to an earlier announcement, technical trading, or unindexed news sources.

The absence of recent news headlines on Yahoo Finance makes it impossible to identify a specific catalyst from the provided evidence. For a small-cap or micro-cap stock like KMRK trading at $2.80, several categories of moves are common even without indexed news: short-squeeze activity (if the stock carries high short interest), technical oversold bounces, delayed reactions to earnings or regulatory filings not yet picked up by major feeds, insider activity, or sector rotation. The stock's rank as the 24th biggest gainer suggests it had notable volume, which is consistent with coordinated buying rather than random noise. Without access to earnings calendars, SEC filings, or broader market context for that date, determining whether this was fundamental or technical is not possible from the available data.

ARBB

ARB IOT Group LimitedTechnology

$5.75+$1.10

+23.7%

NASDAQ · Mkt cap $7.1 M

No news headlines were found in the last 48 hours, so the 23.66% gain on ARBB likely reflects technical trading, sector rotation, a delayed market reaction to an older announcement, or untracked social media interest in the IoT space.

ARB IOT Group Limited jumped nearly 24% on May 4, 2026, but no recent news headlines are available to explain the move directly. This creates an information gap. For a small-cap IoT stock, a single-day surge of this magnitude without identifiable catalyst news could stem from several sources: a technical breakout or covering of a short position, delayed market pricing of an older press release not yet indexed by Yahoo Finance, sector-wide enthusiasm for IoT or similar themes, or buying pressure from retail or algorithmic traders responding to price momentum alone. Without access to company filings, press releases on the company's own website, or social media discussion, we cannot pin the cause to a specific event. The absence of news does not rule out a fundamental catalyst; it only means we lack confirmation.

WAVE

Eco Wave Power Global AB (publ)Utilities

$8.39+$1.51

+21.9%

NASDAQ · Mkt cap $42 M

WAVE jumped 22% after NVIDIA featured Eco Wave Power in a short film showcasing the company's AI-driven wave energy technology, providing significant mainstream tech-sector credibility and visibility.

The single headline reports that NVIDIA published a short film about Eco Wave Power across its global social media platforms, highlighting the company's vision for AI-driven wave energy technology. This represents third-party validation and exposure from one of the world's most prominent technology companies. For a small-cap renewable energy play like WAVE, association with NVIDIA's brand and distribution reach carries material marketing and partnership signal value. The timing of the announcement on May 4 coincides directly with the stock's 22% intraday surge, making causality plausible. The news does not detail a binding contract, revenue commitment, or formal partnership terms, but the visibility boost and implicit endorsement from a mega-cap tech leader is sufficient to drive speculative interest in a growth-stage clean energy company. Investors may also interpret this as validation that wave energy is gaining technological viability and institutional attention.

IPST

IP Strategy Holdings, Inc.Consumer Defensive

$6.70+$1.20

+21.8%

VCX

Fundrise Growth Tech Fund, LLCFinancial Services

$115.00+$20.45

+21.6%

NYSE

No news headlines were available in the last 48 hours, so the 21.63% jump lacks a clear public catalyst; this type of move in a closed-end fund often reflects shifts in underlying tech holdings, sentiment, or technical trading.

VCX is a closed-end fund focused on growth tech equities, and the complete absence of news in the provided 48-hour window means no specific corporate announcement, earnings release, or market event can be identified as the direct trigger. However, a 21.63% single-day move in a fund of this nature can result from several plausible mechanisms. First, if the fund's underlying holdings (growth and tech stocks) experienced a broad rally, the fund would move accordingly, potentially amplified by leverage if present in the fund structure. Second, closed-end funds can experience significant price swings due to changes in the fund's discount or premium to net asset value, particularly in lower-liquidity trading environments. Third, a delayed earnings report or guidance revision from a major holding, or sector-wide news (such as AI or growth-sector tailwinds), could drive the move but would not appear in a standard 48-hour news feed if announced outside that window. Without access to the fund's holdings, structure details, or broader market context for that date, the specific cause remains uncertain.

REPL

Replimune Group, Inc.Healthcare

$3.03+$0.53

+21.2%

NASDAQ · Mkt cap $1.4 B

No news headlines were found in the last 48 hours, so the 21.20% jump likely reflects either a delayed market reaction to earlier news, technical trading, or undetected developments affecting Replimune's clinical or business prospects.

Replimune is a clinical-stage immunotherapy company whose stock typically moves on catalysts tied to clinical trial data, regulatory decisions, partnership announcements, or financing events. The absence of news in the most recent 48-hour window does not rule out a reaction to developments that occurred earlier and may not yet have reached Yahoo Finance RSS feeds, or to analyst commentary and technical factors. Biotech stocks of this stage often exhibit elevated volatility and can gap on volume spikes unaccompanied by same-day news alerts. The magnitude of the gain (21.20%) is material enough that an underlying catalyst almost certainly exists, but without headline confirmation, the specific source remains unclear. Possibilities include positive trial interim readouts, favorable regulatory feedback, partnership activity, or short-covering in a thinly-traded name.

CRCL

Circle Internet GroupFinancial Services

$119.53+$19.83

+19.9%

NYSE · Mkt cap $26 B

Circle Internet Group surged 19.89% following a Senate compromise on stablecoin legislation that resolved yield restrictions, alongside a broader rally in crypto stocks driven by Bitcoin briefly topping $80,000.

Multiple headlines from May 4 establish a clear legislative catalyst. The U.S. Senate reached a bipartisan compromise on the Clarity Act regarding stablecoin yields, which had previously held up crypto industry legislation. One source explicitly states Circle shares surged 16.1% on the news that the compromise appeared less restrictive than feared. Bitcoin's concurrent breakout above $80,000 amplified sentiment across crypto equities, with Coinbase and Circle both highlighted as leading gainers. Additional tailwinds came from the DTCC announcing tokenization services and Western Union launching a regulated stablecoin on Solana, all signaling broader institutional adoption and regulatory clarity. The 19.89% move reflects investor relief that key regulatory uncertainty has been lifted for stablecoin operators like Circle, which issues USDC.

HKIT

Hitek Global Inc.Technology

$0.85+$0.14

+19.7%

NASDAQ · Mkt cap $27 M

No headlines were found in the last 48 hours, so the 19.7% gain on HKIT cannot be attributed to announced news; the driver is likely a technical bounce, delayed reporting, or undisclosed rumor in the micro-cap space.

The absence of any news in the last 48 hours is noteworthy for a stock ranked among the day's top 31 gainers. A nearly 20% move on a sub-dollar stock like HKIT typically correlates with either announced catalysts, earnings surprises, or short-squeeze activity, yet no headlines appear in the data provided. Possible explanations include a delayed news reporting lag in the RSS feed, a technical or algorithmic rebound after a prior sell-off, insider activity, or unverified rumors circulating on forums or social media specific to micro-cap and penny stocks. Without visibility into the company's fundamentals, recent trading patterns, or short interest, it is difficult to assign a specific cause. HKIT's market cap and liquidity profile (trading under $1) make it particularly susceptible to volatile moves driven by relatively small order flows or sentiment shifts.

MSS

Maison Solutions Inc. Class A Common StockConsumer Defensive

$1.46+$0.24

+19.7%

NASDAQ · Mkt cap $1.6 M

No news headlines were found in the last 48 hours, so the 19.67% jump cannot be attributed to a disclosed catalyst; the move may reflect technical trading, short covering, or a delayed announcement not yet picked up by the feed.

The absence of recent news is notable given the stock's significant single-day gain of nearly 20%, which placed it among the top 32 gainers on NASDAQ. For a micro-cap stock like Maison Solutions trading at $1.46, upward moves of this magnitude can be driven by several mechanisms: short squeezes (particularly if the float is tight and short interest is elevated), technical breakouts above key resistance levels, delayed reporting of company announcements, rumor or social media-driven trading, or simple mean-reversion in a volatile security. Without a news trigger in the provided data, we cannot establish which of these factors is responsible. The lack of headline coverage is itself significant—it suggests either that the catalyst remains undisclosed to major financial news aggregators, or that the move is driven purely by trading technicals rather than new fundamental information.

SHPH

Shuttle Pharmaceuticals Holdings, Inc.Healthcare

$0.83+$0.14

+19.5%

NASDAQ · Mkt cap $2.3 M

No news headlines were found in the last 48 hours, so the 19.55% jump cannot be attributed to a specific announced event; the move was likely driven by technical factors, market sentiment, or untracked catalysts such as insider activity or sector rotation.

Shuttle Pharmaceuticals is a small-cap biotech stock trading at $0.83, and the absence of any news in the Yahoo Finance RSS feed over the past two days means we cannot point to a concrete catalyst such as clinical trial results, FDA action, partnership announcements, or earnings. For stocks at this price point and market cap, large single-day moves are common and can be driven by several factors: short-covering or squeeze dynamics if the stock has meaningful short interest, options expiry effects, sector-wide biotech rallies, retail investor accumulation, or simply low trading volume amplifying normal market moves. Without headline evidence, attributing this move to a specific newsworthy event would be speculation. The most honest assessment is that the cause lies outside the scope of major news announcements captured by standard financial feeds.

FSTR

L.B. Foster CompanyIndustrials

$36.60+$5.90

+19.2%

NASDAQ · Mkt cap $389 M

L.B. Foster reported Q1 2026 earnings that beat analyst expectations significantly, with earnings surprise of 165% and revenue 16% above estimates, driving the 19% stock jump.

L.B. Foster released first-quarter results on May 4, 2026 that substantially exceeded Wall Street forecasts. The company reported net sales of $121.1 million, up 23.9% year-over-year, with particularly strong performance in its Rail segment which grew 38.4%. The earnings per share surprise reached 165%, indicating the company was far more profitable than expected. Management described a return to normal demand conditions in rail and continued momentum in precast operations. The company reaffirmed full-year 2026 guidance, suggesting management confidence in sustained performance. These concrete operational outperformance metrics across multiple dimensions explain investor enthusiasm and the substantial single-day gain.

AURA

Aura Biosciences, Inc.Healthcare

$8.35+$1.34

+19.1%

NASDAQ · Mkt cap $778 M

Aura Biosciences announced a $260 million public offering of common stock and pre-funded warrants on May 4, alongside a CEO transition, likely triggering relief that near-term funding needs are secured despite dilution concerns.

The stock's 19% gain coincides with three material announcements on the same day. The most direct catalyst appears to be the pricing of a $260 million equity offering, which demonstrates investor confidence and ensures the company has runway to advance its Phase 3 CoMpass trial toward completion. For clinical-stage biotech firms, securing substantial capital without needing immediate dilutive measures is often viewed favorably by the market. The CEO transition to Natalie Holles, described as having rare disease and commercialization experience, may reinforce confidence in execution. However, equity offerings typically trigger near-term dilution and downward pressure; the magnitude of this positive move suggests the market is weighting the certainty of funded development progress more heavily than the dilution risk. Without detail on the offering terms, warrant pricing, or investor composition, some upside momentum may also reflect technical positioning or relief buying after any pre-announcement uncertainty.

SMTK

SmartKem, Inc.Technology

$0.28+$0.04

+19.1%

NASDAQ · Mkt cap $2.2 M

No news headlines were found in the last 48 hours, so the 19% gain on May 4th likely reflects either a delayed market reaction to an earlier announcement, technical buying pressure, or an untracked rumor or event affecting this small-cap stock.

SmartKem is a micro-cap semiconductor/materials company with historically low liquidity, making it susceptible to outsized moves on minimal volume. The absence of news in the 48-hour window prior to the snapshot does not rule out the possibility that news broke earlier in the week, took time to filter through market participants, or that the move was driven by technical factors such as short covering, options expiration, or algorithmic buying triggered by a price threshold. Small companies in the semiconductor space can also experience sharp moves on sector sentiment shifts, analyst upgrades not yet reflected in major news feeds, or insider transactions. Without identified headlines, we cannot isolate a specific catalyst, only note the characteristics of this name that make it prone to volatile, low-volume swings.

FCHL

Fitness Champs Holdings Limited Common StockConsumer Defensive

$3.08+$0.49

+18.7%

NASDAQ · Mkt cap $1.5 M

No news headlines were found in the last 48 hours, so the 18.69% gain likely reflects technical trading, delayed disclosure, or market sentiment unrelated to recent public announcements.

The absence of any news in the Yahoo Finance RSS feed over the past 48 hours means we cannot point to a specific catalyst such as earnings, guidance, M&A activity, regulatory action, or operational announcements. For a small-cap fitness-related company like FCHL, gainers of this magnitude without accompanying news typically reflect one of several possibilities: technical buying and short covering, delayed disclosure of material information not yet widely indexed, options-related gamma effects, or broad sector sentiment shifts in fitness or consumer health stocks. Without visibility into company filings, insider activity, or social media catalysts during this period, the move remains mechanically unexplained by the data provided. The rank as the 37th biggest gainer suggests meaningful volume participation, but that alone does not identify the driver.

HOUR

Hour Loop, Inc.Consumer Cyclical

$2.44+$0.38

+18.4%

NASDAQ · Mkt cap $65 M

No news headlines were found in the last 48 hours for HOUR, so the 18.45% gain is not directly attributable to any announced event. The move likely reflects technical trading, a delayed market reaction, or untracked catalysts.

Hour Loop Inc. experienced an 18.45% single-day gain without any corresponding news coverage in the Yahoo Finance RSS feed over the preceding 48 hours. This disconnect suggests the price action was driven by factors other than a major announced event such as earnings, guidance, or a corporate transaction. Smaller-cap stocks like HOUR can exhibit outsized moves on thin volume from retail interest, short covering, or technical chart breaks. Alternatively, news may have circulated through non-RSS channels, earnings may have been pre-announced without full headline distribution, or the move could reflect accumulated positive sentiment from prior days that finally manifested in trading activity on this particular date. Without corroborating headlines or structural information about the company, pinpointing the precise catalyst is not feasible.

CRCO

YieldMax CRCL Option Income Strategy ETF

$25.77+$3.97

+18.2%

AMEX

No news headlines were found in the last 48 hours, so the 18% surge likely reflects either a large options-related move in the underlying CRCL security, a market-wide event, or technical trading activity specific to this ETF structure.

YieldMax CRCL Option Income Strategy ETF is a specialized fund designed to generate income through systematic call option selling on the Circular Economy ETF (CRCL). Its price movements are heavily influenced by the underlying CRCL holdings and implied volatility shifts. An 18% jump with zero supporting news in the past two days suggests one of three possible drivers: first, a sharp rally in CRCL or the circular economy sector that wasn't captured in the Yahoo Finance RSS feed; second, a volatility crush or options rebalancing event that altered the fund's positioning; or third, intraday technical trading or index rebalancing activity. Without headline confirmation, attribution remains speculative, though for an options income ETF, volatility regime shifts and underlying asset momentum are typical catalysts.

UPLD

Upland Software, Inc.Technology

$0.72+$0.11

+18.0%

NASDAQ · Mkt cap $13 M

After a 5.8% plunge on May 3rd due to weak Q1 revenue and disappointing guidance, UPLD rebounded 18% on May 4th; the spike likely reflects bargain-hunting, short covering, or a positive follow-up announcement not yet captured in the headline excerpt.

The available headline confirms that Upland Software reported significantly lower year-over-year Q1 revenue and issued disappointing forward guidance, triggering a sharp sell-off on May 3rd. The May 4th rebound of 18% is striking given no new positive news is provided in the snapshot. This suggests either oversold technical conditions attracting value buyers, short-covering by investors who had bet against the stock following the initial drop, or a material positive development (earnings call commentary, activist involvement, strategic announcement, or analyst upgrade) that occurred after the headline cutoff and is not yet reflected in the provided news feed. Without access to intraday commentary or additional announcements from May 4th itself, the precise catalyst remains unclear.

STKE

Sol Strategies Inc. Common SharesFinancial Services

$1.52+$0.23

+17.8%

NASDAQ · Mkt cap $45 M

SOL Strategies announced an $18 million acquisition of HoudiniSwap LLC, a privacy-focused swap aggregator, which likely drove the 17.83% gain as investors reacted positively to the strategic expansion.

On May 4, 2026, SOL Strategies signed a definitive agreement to acquire HoudiniSwap LLC for $18 million. This is a material M&A announcement for a company trading near $1.52 per share. The acquisition of a privacy-focused swap aggregator suggests SOL Strategies is expanding its product offerings and market reach in the decentralized finance space, which may have been viewed favorably by investors as a growth catalyst. The stock's ranking as the 41st biggest gainer of the day, combined with the 17.83% intraday move, aligns temporally with the Monday announcement. Without additional context on the company's recent financial performance, shareholder composition, or market sentiment toward such deals, we cannot definitively rule out other contributing factors, but the timing and materiality of the acquisition strongly suggest it is the primary driver.

FGL

Founder Group Limited Ordinary SharesIndustrials

$2.40+$0.36

+17.6%

NASDAQ · Mkt cap $475 K

FGL jumped 17.65% on May 4, 2026, with no news headlines available in the prior 48 hours, making the exact catalyst unclear but suggesting either delayed news dissemination, technical factors, or market-wide momentum.

No headlines from the last 48 hours are available to explain FGL's strong intraday gain of 17.65%, which ranks it among the day's top 42 gainers on NASDAQ. This absence of concurrent news coverage creates genuine uncertainty about the driver. Possible explanations in this category include: first, a delayed or off-cycle announcement (earnings, guidance, corporate action) that may have been released but not yet indexed in the news feed provided; second, technical factors such as short covering or momentum-driven buying in a lower-liquidity stock; third, sector-wide tailwinds not captured in company-specific headlines. Without additional detail on FGL's sector, market cap, or recent trading patterns, pinpointing the specific catalyst is not possible from the data provided.

FATE

Fate Therapeutics, Inc.Healthcare

$1.80+$0.27

+17.6%

NASDAQ · Mkt cap $298 M

Fate Therapeutics announced three presentations of its off-the-shelf CAR T-cell therapy pipeline at the 2026 ASGCT Annual Meeting, likely driving investor optimism about its clinical-stage programs for cancer and autoimmune diseases.

The company released news on the morning of May 4th announcing multiple presentation slots at a major scientific conference focused on gene and cell therapy. For a clinical-stage biopharmaceutical company, visibility at peer-reviewed scientific forums and public discussion of pipeline progress can signal advancing development timelines and validate therapeutic approaches. The +17.65% single-day gain is consistent with positive sentiment around clinical advancement announcements, particularly for iPSC-derived cell therapy, which remains an emerging and capital-intensive field. The timing of the announcement coinciding with the stock price jump on the same day supports a direct causal link. However, the headline provided does not contain specific clinical data, efficacy results, or regulatory milestones that would normally drive larger institutional moves, suggesting the market is reacting to increased visibility and momentum rather than transformative trial results.

SAFX

XCF Global, Inc. Class A Common StockUtilities

$0.59+$0.09

+17.4%

NASDAQ · Mkt cap $141 M

XCF Global announced Q1 2026 operational updates and confirmed 2027 revenue and production targets at its Rise Reno facility, along with progress on a definitive business combination agreement, likely driving the 17.4% gain.

The headline indicates XCF Global issued a corporate and operational update on 2026-05-04, the same day of the stock's 17.4% jump. The announcement includes establishment of 2027 targets ($110-120M net revenue, 40-43M gallons of renewable fuel production), confirmation of a signed definitive business combination agreement pending closing conditions, and progress toward sustained SAF production at the Rise Reno facility. For a micro-cap renewable fuels company trading below $1, concrete operational milestones and forward guidance with specific numerical targets can attract speculative interest. The signed definitive agreement likely signals reduced deal completion risk. However, the news snippet provided is truncated, so the full scope of the announcement and any additional details remain unknown. The move is reasonable given the news but the magnitude suggests either strong market sentiment toward SAF producers or possible technical factors amplifying the move in a low-priced stock.

ARKR

Ark Restaurants Corp.Consumer Cyclical

$8.05+$1.19

+17.3%

NASDAQ · Mkt cap $20 M

No news headlines were found in the last 48 hours to explain ARKR's +17.35% jump. The move likely stems from technical factors, sector rotation, or market rumors not captured in major news feeds.

The absence of any recent news headlines makes it difficult to pinpoint a specific catalyst for ARKR's strong intraday gain. Ark Restaurants is a small-cap hospitality operator, and moves of this magnitude in such stocks can be driven by several non-news mechanisms: technical buying or short covering, sector-wide hospitality momentum, options expiration effects, or retail trading activity. Smaller stocks with lower trading volumes are also more prone to outsized percentage moves on modest absolute volume. It is also possible that a material announcement (earnings, same-store sales update, debt refinance, or management change) occurred but has not yet been indexed into widely-syndicated financial news feeds. Without corroborating headlines or earnings calendar confirmation, the specific driver remains unidentified.

APADU

A Paradise Acquisition Corp.Financial Services

$14.00+$2.04

+17.1%

ASRT

Assertio Holdings, Inc.Healthcare

$21.61+$3.14

+17.0%

NASDAQ · Mkt cap $152 M

Assertio announced an Amended and Restated Merger Agreement with Garda Therapeutics on May 1, 2026, likely driving the 17% single-day gain as investors reacted positively to updated deal terms.

The headline confirms that Assertio and Garda Therapeutics entered into an amended merger agreement on May 1, 2026, with the announcement made public on May 4. While the full details of the amendment are not provided in the snippet, M&A announcements—especially amended agreements—typically trigger sharp single-day moves when markets perceive the new terms as more favorable than the original deal structure. The timing and magnitude of the gain (17%, ranking 47 of daily gainers) align with a material corporate event. The fact that the agreement was restated and amended suggests the parties negotiated changes that likely improved deal certainty or valuation for Assertio shareholders. Without access to the complete press release text, we cannot identify the specific amendments, but the market reaction indicates positive reception.

MRDN

Meridian Holdings Inc.Consumer Cyclical

$12.85+$1.85

+16.8%

IREG

Leverage Shares 2x Long IREN Daily ETF

$18.67+$2.68

+16.8%

NASDAQ

No news headlines were found in the last 48 hours, but IREG is a 2x leveraged long ETF tracking IREN, so a ~8.4% gain in the underlying stock would mechanically produce approximately this 16.76% move in the fund.

The absence of recent news headlines makes pinpointing a specific catalyst difficult. However, IREG is a daily rebalanced 2x long leveraged ETF, meaning it amplifies the daily returns of its underlying asset IREN by a factor of two. A gain of approximately 8.4% in IREN would mathematically produce a 16.76% gain in IREG. Without access to IREN-specific news or price data, the most likely explanations for IREN's movement fall into typical categories: earnings or revenue surprise, analyst upgrade, industry tailwind, short-covering, or technical breakout. Leveraged ETFs are also sensitive to volatility spikes and can amplify intraday momentum. The lack of headline coverage could indicate the move was driven by technical factors, delayed market reaction to older news, or a smaller-cap stock event not widely reported.

IRE

Daily Target 2X Long IREN ETF

$24.99+$3.55

+16.6%

AMEX

No news headlines appeared in the last 48 hours, but IRE is a 2X leveraged long ETF on IREN, so a strong move in the underlying stock would be amplified roughly twofold in the fund's price action.

No recent news was found in the Yahoo Finance RSS feed for the past 48 hours, so we cannot identify a specific announced catalyst for the 16.56% gain. However, IRE is structured as a daily target 2X leveraged long ETF tracking IREN, meaning it is designed to deliver approximately twice the daily return of its underlying asset. If IREN itself rallied roughly 8% on May 4th, that would mechanically produce a ~16% move in IRE without any separate news event. The most likely explanations for an unleveraged rally in IREN include sector momentum, technical breakouts, short-covering, or delayed news not yet captured in the RSS feed. Without visibility into the underlying's actual price action or any company-specific announcements, we cannot definitively determine what drove IREN higher.

Biggest Losers

Mon, May 4, 2026 50

XNDU

Xanadu Quantum Technologies Limited Class B Subordinate Voting SharesTechnology

$13.99−$22.13

-61.3%

NASDAQ · Mkt cap $3.4 B

Xanadu stock crashed 61% after the quantum computing firm registered nearly 294 million shares for resale related to its SPAC merger, triggering massive dilution concerns among existing shareholders.

The headline directly identifies a share registration event tied to Xanadu's SPAC merger as the trigger. When a company registers a large number of shares for resale, it signals potential dilution of existing equity and often reflects insider or sponsor lockup expirations that could flood the market with selling pressure. The magnitude of the registration—nearly 294 million shares—is substantial relative to typical float for a publicly traded company and creates legitimate concern about downward price pressure from secondary offerings or lockup releases. This type of structural event is a well-documented catalyst for sharp single-day declines in SPAC-related stocks, as it represents a tangible change in the supply-demand dynamic rather than operational or market speculation.

JAGX

Jaguar Health, Inc.Healthcare

$3.25−$3.44

-51.4%

NASDAQ · Mkt cap $4.5 M

Jaguar Health announced expansion of its Neonorm product line into companion animal markets with a new dog product, but this positive development does not explain a 51% single-day crash, suggesting the drop was triggered by other undisclosed news or market factors not captured in the provided hea…

The only headline provided is a product expansion announcement for Neonorm Dog, which is a positive business development extending Jaguar's existing franchise into a new market segment. Product line extensions and market diversification are typically viewed favorably by investors. A 51% single-day plunge is severe and inconsistent with the tone and content of this news. This suggests either a material negative announcement occurred outside the provided headlines, or a market-moving event unrelated to the Neonorm news drove the sell-off. Given Jaguar Health is a small-cap animal health company, possible explanations include unexpected financial distress, clinical trial failure, regulatory setback, dilutive financing, insider selling, or general risk-off sentiment in biotech. Without access to other news sources or market data from May 4, 2026, the true catalyst remains uncertain.

UBXG

U-BX Technology Ltd.Communication Services

$0.62−$0.63

-50.4%

NASDAQ · Mkt cap $11 M

No news headlines were found in the last 48 hours, so the 50% single-day drop cannot be attributed to a disclosed event; the cause remains unclear without additional information.

UBXG experienced a severe 50.39% decline on May 4, 2026, but Yahoo Finance returned no headlines in the prior 48 hours that would explain the move. This absence of reported news is notable given the magnitude of the loss. Possible causes for such a steep drop without visible headlines include delayed disclosure of material information, technical or short-squeeze liquidation, broader sector weakness not yet reflected in headlines, insider selling, or a rumor or event circulating through less formal channels before formal announcement. Penny stocks or smaller-cap Nasdaq issues like UBXG are more prone to volatile moves on thin liquidity with minimal news flow, so the drop may reflect operational deterioration, financing issues, or a delay in expected positive catalysts rather than a discrete announced event.

SDOT

Sadot Group Inc.Consumer Defensive

$0.26−$0.21

-44.9%

NASDAQ · Mkt cap $11 M

No news headlines were available in the last 48 hours for SDOT, so the cause of the 44.91% drop cannot be confirmed from public announcements. The decline likely stems from market sentiment, technical selling, or undisclosed corporate developments.

The absence of recent news headlines in the provided data makes it impossible to pinpoint a specific catalyst for SDOT's sharp 44.91% decline on this date. Given that the stock trades at a low price point ($0.26) and ranks as the fourth biggest loser of the day, the move could reflect several typical triggers for micro-cap or penny stocks: liquidation pressure, margin calls among retail holders, a delayed earnings miss or guidance reduction released through channels not captured in the 48-hour window, insider selling, or a broader sector rotation out of speculative holdings. Without access to the company's actual news flow, filings, or analyst commentary on May 4, 2026, any specific hypothesis remains speculative. The magnitude of the loss suggests meaningful negative sentiment rather than random noise.

ORGN

Origin Materials, Inc.Basic Materials

$1.47−$1.19

-44.7%

NASDAQ · Mkt cap $3.7 M

No news headlines were found in the last 48 hours, so the 44.74% drop cannot be attributed to any identifiable public announcement or reported event. The cause likely falls into technical selling, unconfirmed rumors, or delayed disclosure.

Origin Materials is a materials science company focused on producing sustainable alternatives to conventional plastics and chemicals. A drop of this magnitude with zero supporting news in the prior 48 hours is unusual and suggests either a catalyst that has not yet been reported through major newswires, a technical or momentum-driven selloff, or privately circulated information that has not reached public disclosure. Possible categories of catalyst typical for this type of company include disappointing operational updates, loss of major customer or partnership, production delays, or guidance reductions. However, without headlines or confirmed reports, these remain speculative. The absence of news coverage during such a severe move also suggests the market may be reacting to something that originated before the 48-hour window, or the information has not yet been formally announced.

CHARR

Charlton Aria Acquisition Corporation

$0.08−$0.05

-38.3%

NASDAQ

No news headlines were reported in the last 48 hours, so the 38% drop cannot be attributed to a specific announced event; the decline is likely driven by technical selling, liquidity constraints typical of micro-cap SPACs, or undisclosed market developments.

Charlton Aria is a SPAC trading at $0.08, well below the typical $10 issuance price, indicating significant deterioration in shareholder value and trust. The absence of any news in the last 48 hours means the reported price collapse was not triggered by a disclosed catalyst such as earnings, merger announcement, regulatory action, or guidance revision. For blank-check companies at this price level, common drivers of sharp declines include loss of investor confidence in management, failure to announce a business combination within expected timelines, redemption activity, insider selling, or reduced liquidity. The severity of the move in a low-float micro-cap can also reflect thin trading and technical selling momentum. Without access to recent filings, press releases, or social media commentary, attribution remains speculative.

AIOS

AIOS Tech Inc.Financial Services

$15.52−$6.48

-29.5%

NASDAQ · Mkt cap $2.7 M

About AIOS Tech Inc.

AIOS Tech Inc. functions as an investment holding company, providing technology-centric integrated financing solutions and comprehensive supply chain services throughout China. The company specializes in offering sophisticated financing services to small and medium-sized enterprises (SMEs). This includes the conceptualization and detailing of debt financial products, alongside providing strategic advisory to underwriters and various financial institutions. Furthermore, AIOS facilitates the entire financing process, from initial due diligence and regulatory registration to client acquisition, investor education, and crucial intermediary and advisory matching services. On the supply chain front, the company leverages cutting-edge technologies such as big data, artificial intelligence (AI), the Internet of Things (IoT), and blockchain. These innovations underpin its supply chain management solutions, primarily serving sectors like agriculture, infrastructure, maritime logistics, energy, and plastics products. Beyond management, AIOS engages in extensive supply chain trading across diverse industries, including agriculture, coal, new energy technology, construction, e-commerce, retail, and the food and vegetable sectors. Additionally, through its Huijingshe platform, the company provides direct banking services, specializing in asset allocation and financial planning for both institutional and individual investors. Rounding out its portfolio, AIOS offers a wide array of auxiliary services. These range from customer management, consulting, and advisory support to comprehensive product inspection, testing, documentation, and freight forwarding. The company also handles customs clearance, warehousing, strategic planning, sourcing, procurement, and all aspects of logistics and transportation, including storage. Formerly known as Nisun International Enterprise Development Group Co., Ltd., the company officially adopted the name AIOS Tech Inc. in February 2026. Established in 2005, its operations are headquartered in Shanghai, China.

Financial - Credit Services · ir.aiosinc.com

AIOS Tech Inc. dropped 29.45% with no news headlines in the last 48 hours, making the specific catalyst unclear. The decline likely stems from broad market factors, technical selling, delayed news coverage, or sector-wide headwinds affecting technology stocks.

No news headlines are available in the last 48 hours to explain AIOS's sharp 29.45% decline, which places it among the day's seven biggest losers. When a stock falls this sharply without accompanying news coverage on major financial feeds, the cause typically falls into a few categories. First, the news may exist but has not yet been indexed by Yahoo Finance RSS, or it may have broken after market close on May 3rd. Second, the move could reflect technical selling pressure, margin calls, or shifts in sector momentum affecting smaller technology stocks broadly. Third, a rumor or unconfirmed report circulating on social media or alternative channels could have triggered institutional or retail selling. Without access to the stock's earnings schedule, recent guidance, product announcements, or insider trading alerts, we cannot identify the specific event. The size of the move suggests something material rather than everyday volatility.

CCOI

Cogent Communications Holdings, Inc.Communication Services

$16.37−$6.79

-29.3%

NASDAQ · Mkt cap $512 M

Cogent Communications plunged 29% after reporting Q1 2026 earnings that missed revenue expectations (down 3.2% year-over-year) and posted a GAAP loss of $0.83 per share, disappointing the market despite a beat on earnings per share.

Cogent reported Q1 2026 results on May 4th showing service revenue of $239.2 million, representing a 3.2% year-over-year decline and missing Wall Street estimates by 0.07%. While the company beat earnings expectations by 19.57% with a loss of $0.83 per share, the top-line miss combined with declining revenues appears to have driven the severe selloff. The earnings call highlighted progress on monetizing former Sprint assets and refinancing plans, but these forward-looking items were insufficient to offset investor concerns about shrinking revenues. For an internet services provider, sustained revenue declines signal market share losses or demand weakness, which typically trigger sharp repricing regardless of near-term profitability beats.

DEVS

DevvStream Corp. Common StockIndustrials

$0.22−$0.09

-28.4%

NASDAQ · Mkt cap $4.8 M

DevvStream announced an exclusive partnership with PT PLN Indonesia for carbon credit management and provided a corporate financing update on May 4, 2026, but the 28.42% intraday drop suggests market concern over the financing terms, deal structure, or dilution implications rather than enthusiasm…

The headline confirms DevvStream secured an exclusive agreement with a major Indonesian power utility for carbon credit management of a solar portfolio, which on surface appears strategically positive for a carbon management firm. However, the stock fell sharply the same day, indicating the market's negative interpretation of something within the announcement or the accompanying financing update. The phrase "provides corporate financing update" is vague but often signals dilutive equity issuance, debt refinancing at unfavorable terms, or disclosures about burn rate and cash runway. Without the full press release text, the exact financing structure remains unclear. Micro-cap stocks like DEVS (trading at $0.22) are highly sensitive to dilution announcements and cash position disclosures. The sell-off likely reflects either negative surprise about capital needs or terms rather than rejection of the business development itself.

ADTX

Aditxt, Inc.Healthcare

$0.14−$0.06

-28.2%

NASDAQ · Mkt cap $2.3 M

No news headlines were found in the last 48 hours, so the 28% drop cannot be attributed to a specific announced event; the move likely reflects either a delayed market reaction to prior news, technical selling pressure, or company-specific rumors not yet picked up by major news outlets.

The absence of any headlines in the last 48 hours is notable for a stock experiencing the tenth-largest single-day loss on the exchange. This suggests the catalyst either predates the 48-hour window, emerged from sources outside mainstream financial news feeds, or is purely technical in nature. Aditxt is a small-cap biotech company, and stocks in this category are historically sensitive to clinical trial results, regulatory decisions, partnership announcements, or changes in cash runway guidance. Without documented news, the most likely explanations are a delayed market reaction to older clinical or financial developments, short-covering reversal, or a company announcement made through non-traditional channels that has not yet been indexed by Yahoo Finance RSS. Sector rotation away from biotech or broader market weakness could provide secondary context, but neither would explain such a disproportionate single-stock decline on its own.

AKAN

Akanda Corp.Healthcare

$41.08−$16.01

-28.0%

NASDAQ · Mkt cap $2.6 M

Akanda Corp. dropped 28% on May 4, 2026, but no news headlines are available in the last 48 hours to explain the move, leaving the specific catalyst unknown.

The absence of any identifiable news in the provided feeds is notable given the severity of the 28% single-day decline, which ranks AKAN among the top losers. For a cannabis-focused company like Akanda, typical catalysts that drive sharp moves include regulatory setbacks, earnings disappointments, licensing or compliance issues, shifts in company guidance, sector-wide pullbacks, or changes in major distributor relationships. Without headline visibility, the decline could reflect delayed news from an earlier announcement, a private development disclosed via alternative channels, technical selling pressure, or sector rotation. The lack of recent coverage also raises the possibility of a material event announced after the RSS feed cutoff or via channels not captured in this headline aggregation.

ULH

Universal Logistics Holdings, Inc.Industrials

$16.13−$6.27

-28.0%

NASDAQ · Mkt cap $487 M

The provided headline about small-cap mispricings is too generic to explain a 28% single-day drop in ULH stock. No specific news about Universal Logistics Holdings was disclosed in the available feed, leaving the precise catalyst unclear.

The only recent headline available is a general commentary on small-cap stock volatility and analyst coverage gaps, which does not address ULH specifically or provide any company-specific catalyst. A 28% single-day loss in a logistics company typically stems from material events such as earnings misses, margin compression warnings, loss of a major contract, debt covenant issues, or broader sector disruption. Without company-specific headlines, three categories of cause are plausible but unconfirmed: (1) an earnings release or guidance cut issued after the headline cutoff, (2) negative commentary from management or analysts regarding freight demand or pricing power in the sector, or (3) a late-day market announcement affecting the transportation or logistics vertical. None of these can be confirmed from the evidence provided.

XXII

22nd Century Group, Inc.Consumer Defensive

$0.99−$0.38

-27.6%

NASDAQ · Mkt cap $1.4 M

XXII dropped 27.59% on the day an earnings announcement for May 7 was released, suggesting investor disappointment or short-covering ahead of results, though the headline itself does not disclose negative guidance or preliminary numbers.

On May 4, 22nd Century Group announced it will report Q1 2026 earnings on May 7. The timing of a 27.59% single-day plunge coinciding with an earnings announcement is noteworthy, but the actual headline provides no negative detail—no pre-announced miss, no guidance cut, and no operational setback. This creates ambiguity. One possibility is that the market had built in rosier expectations and the mere announcement of results three days out triggered profit-taking or short-covering in a volatile, low-priced stock. Alternatively, the drop may reflect broader sector headwinds, a technical breakdown in a beaten-down name, or investor concern about competitive or regulatory pressures in reduced-nicotine tobacco products. Without disclosed guidance or preliminary numbers in the headline, we cannot attribute the move to a specific corporate event.

CWD

CaliberCos Inc.Financial Services

$0.80−$0.29

-26.6%

NASDAQ · Mkt cap $4.6 M

CWD dropped 26.61% on May 4, 2026, but no news headlines were available in the prior 48 hours to explain the move, leaving the cause unclear.

No recent news was found in the Yahoo Finance RSS feed for the 48 hours leading up to this sharp decline. This absence of corroborating headlines makes it difficult to pinpoint a specific catalyst. For a micro-cap stock trading at $0.80, the move could reflect several generic mechanisms: an after-hours or pre-market announcement not yet indexed by the news feed, technical selling or forced liquidation, delayed disclosure of negative company developments, insider trading signals, or market-wide volatility affecting thinly traded securities disproportionately. Without access to real-time press releases, SEC filings, or intraday corporate communications, we cannot definitively attribute this 26% single-day loss to any particular event. The rank as the 14th biggest loser suggests broad market participation in the sell-off rather than isolated activity.

CVM

CEL-SCI CorporationHealthcare

$1.69−$0.59

-25.9%

KWM

K Wave Media Ltd.Communication Services

$0.31−$0.11

-25.7%

NASDAQ · Mkt cap $114 M

No news headlines were found in the last 48 hours, so the 25.7% drop cannot be attributed to any publicly announced event. The move likely reflects technical selling, delayed news from an earlier period, or market sentiment unrelated to identifiable catalysts.

KWM experienced a steep single-day decline with zero supporting news in the Yahoo Finance RSS feed for the preceding two days. Without earnings reports, guidance changes, regulatory actions, or material announcements to explain the move, the cause remains opaque. Micro-cap stocks trading under one dollar are typically more sensitive to technical factors, retail trading flows, and sentiment shifts that may not generate immediate press coverage. The absence of news does not rule out a delayed market reaction to older announcements, insider activity, sector rotation, or changes in sentiment among thinly traded securities. Without additional context on the company's business, recent performance, or broader market conditions for media or technology stocks on that date, identifying a specific catalyst is not possible.

COAG

Hemab Therapeutics Holdings, Inc. Common StockHealthcare

$25.34−$8.66

-25.5%

NASDAQ · Mkt cap $2.4 B

Hemab Therapeutics IPO closed on May 4 at $34, but the stock fell 25.47% to $25.34 the same day, likely due to typical post-IPO profit-taking and investor reassessment of a clinical-stage biotech with pipeline risk.

The headlines confirm Hemab completed its IPO on May 3–4, 2026, with the stock opening at $34 per share. The May 3 article explicitly notes the company is "clinical-stage" and flags "pipeline risks" as a key focus. The 25% single-day drop from the $34 IPO price is consistent with post-IPO volatility, where early investors and underwriter allocations frequently take profits, and broader market participants reassess valuations. For a clinical-stage biotech with no revenue, investors would naturally be skeptical of initial IPO pricing. The stock's inclusion as the 17th biggest loser of the day suggests broader selling pressure, though the news provides no indication of a specific adverse event, trial data miss, or regulatory setback that would warrant deeper analysis beyond typical IPO dynamics.

AREB

American Rebel Holdings, Inc.Consumer Cyclical

$0.24−$0.08

-25.0%

NASDAQ · Mkt cap $4.8 M

American Rebel Holdings fell 25% on May 4th with no news headlines in the last 48 hours, making the specific catalyst unclear; the drop likely reflects either a delayed market reaction to an untracked announcement, technical selling, or sector-wide pressure.

No headlines from Yahoo Finance RSS in the last 48 hours provide direct explanation for the 25% single-day decline. This is a micro-cap equity trading at $0.24, which typically exhibits higher volatility and lower information efficiency than large-cap stocks. The lack of tracked news does not rule out an actual catalyst; smaller companies often experience moves driven by untracked social media activity, private investor selling, sector rotation, or delayed reactions to earlier announcements that did not reach major wire services. Alternatively, technical factors such as stop-loss cascades or algorithmic selling in thinly-traded securities can amplify intraday moves. Without access to Level 2 volume data, insider filings, or coverage from microcap-focused sources, the proximate cause remains speculative.

DVLT

Datavault AI Inc.Technology

$0.56−$0.18

-24.7%

NASDAQ · Mkt cap $253 M

Datavault AI announced an all-share acquisition of CyberCatch, which likely triggered the 24.71% drop due to shareholder dilution concerns and market skepticism about the deal's value creation.

The sole headline from the past 48 hours is the announcement that Datavault AI will acquire CyberCatch in an all-share transaction. All-share deals are commonly viewed negatively by existing shareholders because they increase share count without immediate cash or asset backing perceived as offsetting the dilution. The market's reaction suggests investors may be concerned about whether CyberCatch's AI-powered compliance and threat simulation capabilities justify the dilution, or whether integration risks and execution challenges outweigh strategic benefits. Without details on deal terms, valuation multiples, or management guidance on accretion or synergies, investors have defaulted to a sell-the-news response typical of dilutive M&A announcements in smaller-cap stocks. The significant one-day drop suggests material negative sentiment toward the transaction structure or the target company itself.

GSUN

Golden Sun Education Group LimitedConsumer Defensive

$0.43−$0.14

-24.2%

NASDAQ · Mkt cap $3.5 M

No news headlines were available in the last 48 hours, so the 24% drop cannot be attributed to a specific announced catalyst. The decline likely stems from technical selling, sector rotation, or undisclosed company developments.

Golden Sun Education Group experienced a sharp 24% single-day decline on May 4, 2026, ranking among the day's worst performers. However, no news articles appeared in the Yahoo Finance RSS feed during the preceding 48 hours. This creates an information gap: either the catalyst occurred before the 48-hour window, emerged through non-traditional channels, or the move was driven by technical factors rather than fundamental news. Education stocks can be sensitive to policy changes, enrollment data, regulatory shifts in their operating jurisdictions, or shifts in investor appetite for the sector. Without access to company filings, insider transactions, or press releases issued directly by GSUN, we cannot confirm whether this was event-driven or momentum-based selling. The stock's low price point ($0.43) also suggests it may be microcap or distressed, making it more prone to volatility unrelated to headline news.

FWRD

Forward Air CorporationIndustrials

$16.22−$5.11

-24.0%

NASDAQ · Mkt cap $551 M

No news headlines were found in the last 48 hours for Forward Air Corporation, so the 23.96% single-day drop cannot be directly attributed to a specific announced catalyst based on available information.

The absence of any Yahoo Finance headlines in the last 48 hours makes it impossible to identify a definitive cause for the sharp 23.96% decline. For a transportation and logistics company like Forward Air, typical catalysts for large single-day moves include quarterly earnings misses, guidance reductions, loss of major contracts, competitive pressures, or shifts in freight demand. The magnitude of this drop—ranking 21st among daily losers—suggests a material negative event, but without news coverage it could represent a delayed market reaction to a prior announcement, insider activity, options-related technical pressure, or sector-wide weakness in freight or logistics stocks not captured in the headline feed. The timing of May 4, 2026 offers no obvious macro context without additional research.

GAUZ

Gauzy Ltd. Ordinary SharesTechnology

$0.52−$0.16

-23.3%

NASDAQ · Mkt cap $6.9 M

No news headlines were found in the last 48 hours, so the 23.27% drop cannot be directly attributed to a reported event. The cause likely stems from technical selling, delayed news, or market-wide factors affecting small-cap equity.

Gauzy Ltd. is a small-cap equity on NASDAQ experiencing a severe single-day decline with zero news coverage in the provided 48-hour window. This disconnect between price action and reported headlines makes causal attribution difficult. Small-cap stocks like Gauzy are typically more volatile and sensitive to several factors beyond major news events: technical support level breaks, accumulation of negative sentiment across multiple trading days, derivative-related positioning, or delayed disclosure of material information not yet captured in Yahoo Finance RSS feeds. Additionally, broad market weakness in small-cap or technology-adjacent sectors could have driven indiscriminate selling. Without a specific headline, we cannot pinpoint whether this reflects company-specific bad news, sector rotation, or pure technical momentum.

PAPL

Pineapple Financial Inc.Financial Services

$1.14−$0.33

-22.4%

AMEX · Mkt cap $25 M

No news headlines were found in the last 48 hours for PAPL, so the 22.45% single-day drop cannot be attributed to any publicly reported catalyst. The cause remains unknown without additional information.

The absence of news in the provided RSS feed means there is no documented headline-driven explanation for the sharp decline. For a micro-cap stock like PAPL trading at $1.14, several typical categories of catalyst could explain such a move: sudden earnings disappointment or guidance cut, executive departure, regulatory or compliance action, loss of a major customer or contract, debt covenant breach, dilutive financing announcement, or broader sector rotation out of small-cap names. Alternatively, the drop could reflect technical selling, short-covering reversals, or reaction to news reported outside the monitored RSS feeds. Without access to conference calls, SEC filings, or direct company announcements, the specific trigger remains speculative.

TORO

Toro Corp.Energy

$6.01−$1.67

-21.7%

NASDAQ · Mkt cap $193 M

No news headlines were found in the last 48 hours, so the 21.74% decline cannot be directly tied to a specific public announcement. The move may reflect a delayed market reaction to an earlier event, broad sector weakness, or market-moving news that has not yet appeared in the feed.

Without recent headlines, we cannot identify a specific catalyst for Toro's sharp 21.74% drop. Toro Corp, a diversified manufacturer of outdoor equipment and turf maintenance products, typically responds to earnings announcements, guidance revisions, competitive pressures, or macroeconomic signals affecting construction and landscaping demand. A loss of this magnitude in a single day would normally be accompanied by material news—earnings miss, major contract loss, dividend cut, or significant litigation—but no such announcements appear in the available data. The decline could represent a delayed reaction to news released earlier than 48 hours ago, a technical or liquidity event, or news that has not yet propagated to the Yahoo Finance feed. Without additional context, attribution remains speculative.

UPSG

Leverage Shares 2x Long UPS Daily ETF

$13.27−$3.67

-21.7%

NASDAQ

No news headlines were found in the last 48 hours, but UPSG is a 2x leveraged long ETF on UPS, so a sharp 21.66% decline most likely reflects a significant drop in UPS stock itself, possibly triggered by company-specific or broader logistics sector weakness.

The absence of recent headlines makes direct attribution impossible. However, UPSG is a daily reset 2x leveraged ETF tracking UPS, meaning its price movements amplify the underlying stock's moves by roughly double. A 21.66% drop in UPSG implies approximately an 10-11% decline in UPS shares. This magnitude of move typically requires a material catalyst: earnings miss or guidance reduction, negative industry commentary, operational disruption, or broader sector selloff affecting transportation and logistics. Without visible news in the provided feed, the catalyst may have occurred earlier, been delayed in publishing, or be reflected in intraday trading data not captured here. The leveraged structure amplifies both gains and losses, making UPSG particularly volatile on down days in its underlying.

EMISR

Emmis Acquisition Corp. Rights

$0.11−$0.03

-21.4%

NASDAQ

No news headlines were found in the last 48 hours, so the 21% decline likely stems from typical SPAC rights volatility, broad market movement, or technical factors affecting low-priced securities.

Emmis Acquisition Corp. Rights are a SPAC-related security trading at $0.11, a price point where single-cent moves translate to large percentage swings and where trading volume and liquidity can be thin. With zero news coverage in the past two days, the decline cannot be tied to company-specific announcements, earnings, or deal developments. For rights offerings on blank-check companies, common drivers of price action include shifts in sentiment toward the underlying SPAC merger prospects, redemption dynamics, implied warrant or common stock deterioration, or simply low-liquidity technical moves. Without news or filing data, the precise trigger is not identifiable from the evidence provided. Broad market weakness on 2026-05-04 or sector rotation away from SPAC plays could also explain the move.

EZGO

EZGO Technologies Ltd.Consumer Cyclical

$1.23−$0.33

-21.2%

NASDAQ · Mkt cap $2.6 M

No news headlines were published in the last 48 hours, so the 21.15% decline cannot be traced to a specific announced catalyst. The drop likely reflects broad market pressure, technical selling, or undisclosed company developments.

The absence of any news in the Yahoo Finance RSS feed for the past 48 hours means we cannot point to an earnings miss, product announcement, regulatory action, or guidance change as the direct cause. EZGO Technologies is a small-cap stock trading at $1.23, and such securities are often subject to higher volatility and susceptible to technical selling pressure, insider moves, or rumors that may not immediately surface in major news feeds. The move could also reflect delayed disclosure of information already known to market participants, a shift in sector momentum, or a company-specific event not yet widely reported. Without headlines or structural details about EZGO's business model or capital structure, attributing the loss to a particular event would be speculation.

CREG

Smart Powerr Corp.Utilities

$0.44−$0.11

-20.6%

NASDAQ · Mkt cap $499 K

No news headlines were found in the last 48 hours, so the cause of the 20.62% drop cannot be determined from available evidence. The decline likely stems from technical selling, market sentiment, or undisclosed company developments.

Smart Powerr Corp. experienced a sharp single-day decline ranking it among the 28 biggest losers on NASDAQ, yet no recent news articles are available to explain the move. This disconnect between the magnitude of the price action and the absence of public information is notable. For a micro-cap stock trading at $0.44, causes could include: selling pressure from a dilutive capital raise or insider transaction not yet widely reported, negative momentum in a thematic sector (power or renewable energy), technical breakdown below key support levels, or delayed market reaction to an older announcement. Without access to SEC filings, insider trading reports, or real-time company communications issued within the snapshot window, we cannot pinpoint the specific catalyst. The lack of Yahoo Finance coverage in the 48-hour period makes this analysis heavily constrained.

PMI

Picard Medical, Inc.Healthcare

$0.35−$0.09

-19.7%

AMEX · Mkt cap $6.8 M

PMI fell 19.72% with no news reported in the last 48 hours, making it impossible to identify a specific catalyst from public headlines; the drop likely reflects either broader market weakness, a delayed announcement, or a rumor confined to small-cap trading channels.

No financial news, earnings reports, regulatory actions, or corporate announcements appear in the available headlines for PMI over the past two days. A nearly 20 percent single-day decline on an AMEX-listed micro-cap stock with no identifiable news catalyst suggests the move could be driven by several categories of factors. First, broad market weakness or sector rotation could have hit smaller, less liquid names disproportionately. Second, for a stock trading at $0.35, movements can be amplified by thin trading volumes and intraday momentum. Third, the absence of headlines does not rule out material news breaking on bulletin boards, private communications, or delayed SEC filings that Yahoo Finance has not yet indexed. Fourth, technical capitulation or forced liquidations could explain the drop. Without corroborating news or structural market intelligence about PMI itself, determining the true driver remains speculative.

PTIX

Protagenic Therapeutics, Inc.Healthcare

$0.72−$0.16

-18.2%

NASDAQ · Mkt cap $652 K

No news headlines were reported in the last 48 hours, so the 18% drop cannot be attributed to a specific announced event; the decline likely reflects broad biotech sector weakness, a delayed news release, or technical selling pressure.

The absence of any news headlines in the 48-hour window preceding this sharp 18% decline makes it impossible to identify a specific catalyst from public announcements. Protagenic Therapeutics is a small-cap biotech stock trading at $0.72, a price range and market segment typically sensitive to clinical trial data releases, FDA decisions, financing announcements, or insider transactions. The magnitude of the drop suggests something material occurred, but without supporting headlines it could reflect several categories of cause: a news event that has not yet propagated to Yahoo Finance RSS, a conference presentation or clinical update disclosed through a channel not captured by the feed, technical selling driven by a resistance level break or short-seller activity, or broader biotech sector pullback that caught this name particularly hard. The absence of evidence is not evidence of absence of news; it may simply indicate a lag in headline aggregation or a direct company disclosure not yet indexed.

STAK

STAK Inc. Ordinary SharesEnergy

$0.95−$0.21

-17.8%

NASDAQ · Mkt cap $29 M

No news headlines were available in the last 48 hours to explain STAK's 17.81% decline, so the cause remains unknown without access to additional information about company announcements, market conditions, or trading activity.

The absence of any reported news in the last 48 hours makes it impossible to identify a specific catalyst for STAK's sharp one-day drop of 17.81%. The stock is trading at $0.95, which suggests it may be a micro-cap or distressed security where price movements can be volatile and driven by factors other than headline news. Possible explanations in this context could include technical selling or liquidation pressure, a delayed announcement not yet picked up by news feeds, sector-wide weakness in an uncovered industry segment, or low-volume trading amplifying normal price swings. Without access to real-time company filings, insider transactions, or social media activity that might signal a developing story, we cannot determine whether this is a temporary technical move or reflects material adverse information not yet reflected in major news sources.

GXO

GXO Logistics, Inc.Industrials

$46.27−$9.95

-17.7%

NYSE · Mkt cap $5.4 B

GXO Logistics fell 17.7% after a headline flagged Amazon as a competitive threat to the company's growth outlook, suggesting Amazon's logistics expansion could erode GXO's market position and future revenue prospects.

The single available headline directly attributes the sharp decline to Amazon-related competitive pressure. The headline states Amazon's new business poses a threat to GXO's growth outlook, but provides no additional specifics about the nature of Amazon's new offering, whether it targets GXO's core customer base, or quantified impact estimates. The headline's phrasing ("Here's Why GXO Logistics Shares Slumped") confirms causality in the market's eyes. GXO is a logistics and warehousing company heavily dependent on third-party contract opportunities, making it legitimately vulnerable to vertical integration by Amazon, its potential customer and competitor. However, the headline alone does not reveal whether this threat is newly announced, newly disclosed, or a market reassessment of existing competitive dynamics.

WATT

Energous CorporationTechnology

$28.22−$6.03

-17.6%

BIYA

Baiya International Group Inc. Ordinary SharesTechnology

$1.19−$0.25

-17.4%

NASDAQ · Mkt cap $71 M

No news headlines were found in the last 48 hours, so the 17.36% single-day drop cannot be attributed to a specific announced event; the cause remains unknown without additional context.

The absence of any headlines in the last 48 hours makes it impossible to pinpoint a concrete catalyst for BIYA's sharp 17.36% decline. This lack of news coverage rules out major announced events such as earnings misses, guidance withdrawals, regulatory actions, or M&A news. For a micro-cap or thinly traded stock like BIYA trading below $1.20, declines of this magnitude can result from several categories of factors: technical selling tied to moving average breaks or algorithmic liquidations, delayed disclosure of unfavorable private developments that haven't yet reached headlines, sector-wide weakness in the relevant industry, or shifts in sentiment among a small holder base. Without visibility into trading volume, short interest, or the company's fundamentals, attribution remains speculative.

COHN

Cohen & Company Inc.Financial Services

$15.26−$3.16

-17.2%

AMEX · Mkt cap $38 M

Cohen & Company (COHN) fell 17.16% on May 4, 2026, likely triggered by Q1 2026 earnings results reported on May 2 that apparently disappointed the market despite mentions of platform growth and expanding repo business.

The most relevant news headline is the Institutional Financial Markets Q1 earnings call from May 2, which reported first-quarter 2026 results. The snippet mentions continued growth in the capital markets platform and expansion of the gestation repo business, which on their surface sound positive. However, earnings calls often contain guidance resets, margin pressure, or forward-looking concerns that the market reacts to negatively. The timing—earnings called on May 2, stock drops sharply on May 4—is consistent with a delayed sell-off following disappointing results or weakened guidance. Without the full earnings release, we cannot identify the specific metric that triggered the decline, but the magnitude suggests material disappointment rather than a technical or rumor-driven move. The Qrypt headline appears unrelated to COHN's operations.

TRT

Trio-Tech InternationalTechnology

$11.67−$2.39

-17.0%

AMEX · Mkt cap $114 M

No news headlines were available in the last 48 hours, so the 17% decline in Trio-Tech International cannot be directly attributed to a specific announced event. The drop likely reflects either technical selling, a delayed or unannounced corporate development, or broader market weakness in the st…

The absence of recent news headlines makes it impossible to identify a concrete catalyst for the 17% single-day loss. Trio-Tech International is a small-cap electronics manufacturer and testing services provider, historically sensitive to semiconductor cycle fluctuations, defense contracting developments, and earnings surprises. Without available news, the decline could reflect several categories: (1) delayed reporting of an earnings miss or guidance reduction that hit the wire before being indexed in RSS feeds, (2) a technical breakdown after resistance levels or forced liquidation, (3) an unannounced insider transaction or material event not yet public, or (4) sector-wide weakness affecting smaller electronics and testing firms. Small-cap stocks are also prone to lower liquidity and higher volatility on modest volume.

GPRO

GoPro, Inc.Technology

$1.44−$0.29

-16.8%

RYOJ

rYojbaba Co., Ltd. Common SharesIndustrials

$2.19−$0.44

-16.7%

NASDAQ · Mkt cap $53 M

No news headlines were available in the last 48 hours to explain the 16.73% drop in RYOJ stock. Without reporting on earnings, guidance, regulatory action, or other specific catalysts, the cause remains unclear.

The absence of news in the last 48 hours makes it impossible to pinpoint a concrete driver for RYOJ's decline to rank 38 among the day's biggest losers. The stock could have fallen due to several unmeasured categories: a delayed earnings miss or warning announced outside the headline feed window, sector-wide weakness in small-cap or micro-cap equities, technical selling pressure or short covering, insider transactions, or untracked developments in company-specific operations. Without access to the full information environment—including pre-market announcements, conference calls, SEC filings, social media signals, or sector rotation—attributing the move to any particular cause would be pure speculation rather than evidence-based analysis.

SHMD

SCHMID Group N.V. Class A Ordinary SharesIndustrials

$5.31−$1.06

-16.6%

NASDAQ · Mkt cap $343 M

No news headlines were found in the last 48 hours to explain the 16.64% decline, so the driver remains unclear without access to intraday events or market data beyond the headlines provided.

The absence of recent news headlines makes it impossible to identify a specific catalyst for SHMD's sharp 16.64% single-day drop. This kind of magnitude move in a small-cap or micro-cap stock typically correlates with one of several event categories: earnings disappointment or guidance cut, a material corporate action or restructuring announcement, regulatory setback, insider selling or lock-up expiration, debt or liquidity concerns, or broad sector weakness. Without headline confirmation of any of these, the move remains unexplained by the available public information. It is possible the triggering event occurred intraday or before market open and has not yet been captured in the RSS feed, or the stock experienced a technical liquidation or options-driven cascade without fundamental news. More current data would be needed to determine the actual cause.

FBYD

Falcon's Beyond Global, Inc. Class A Common StockIndustrials

$13.58−$2.62

-16.2%

NASDAQ · Mkt cap $387 M

No news headlines were found in the last 48 hours, so the 16% drop likely stems from company-specific developments, market technicals, or sector headwinds not yet reflected in major news feeds.

The absence of recent headlines makes it difficult to pinpoint a specific catalyst for the 16.15% decline. Falcon's Beyond Global operates in the experiential entertainment and virtual reality space, sectors that can be sensitive to funding announcements, partnership developments, or guidance shifts. Possible explanations falling into the inference category include: (1) delayed news of a disappointing earnings report, capital raise at an unfavorable price, or partnership dissolution not yet indexed in mainstream feeds; (2) technical selling or short accumulation if the stock has been volatile or is held by a concentrated shareholder base. Without confirmed headlines, these remain hypotheses rather than established causes.

NSSC

Napco Security Technologies, Inc.Industrials

$39.61−$7.11

-15.2%

NASDAQ · Mkt cap $1.3 B

NSSC plummeted 15.22% on May 4 despite positive Q1 earnings that met expectations and a strong year-to-date rally, suggesting the sell-off may reflect profit-taking or a disappointment in forward guidance not clearly captured in the headlines provided.

The headlines present a puzzling picture. On the surface, NSSC reported Q1 2026 results in line with expectations, with 11.8% year-over-year revenue growth to $49.17 million and a near-break-even GAAP result better than feared. The stock had rallied 67% over the prior year and the earnings were characterized as met or exceeded. However, the first headline explicitly states the stock "plummeted," indicating the market's reaction was decidedly negative despite these ostensibly positive fundamentals. One headline references a $16 million charge disclosed in Q3 results, which could explain investor concern, though the full context is missing. The most plausible explanation is that while headline numbers were acceptable, forward guidance was either withdrawn, reduced, or cautionary in tone during the earnings call, or investors interpreted margins or guidance negatively in real time, triggering a substantial sell-off and profit-taking after the year-long rally.

SLNH

Soluna Holdings, Inc.Financial Services

$1.34−$0.24

-15.2%

NASDAQ · Mkt cap $294 M

Soluna announced new Project Dorothy partnerships and Briscoe Wind Farm expansion, but the headline framing as a "valuation check" suggests investor skepticism about whether the growth justifies current valuation, triggering a 15% sell-off on a micro-cap crypto-related stock prone to volatility.

The news headline itself is positive on the surface—new partnerships and capacity additions at a renewable-powered data center project for Bitcoin mining represent business expansion. However, the phrase "valuation check" signals that analysts or the market may be questioning whether these developments are sufficient to support SLNH's current stock price. This is consistent with how micro-cap renewable energy and cryptocurrency infrastructure plays often trade: initial enthusiasm followed by sharp corrections when growth announcements fail to meet inflated expectations or when valuation multiples compress. Without the full article, we cannot determine if there were missed guidance metrics, disappointing financial details embedded in the announcement, or simply a reassessment of fair value. The 15% single-day drop on modest positive news is typical of thinly-traded, high-beta stocks where sentiment can shift rapidly and small capital flows create outsized moves.

ENVB

Enveric Biosciences, Inc.Healthcare

$3.41−$0.58

-14.5%

NASDAQ · Mkt cap $5.3 M

No headlines were available in the last 48 hours to explain the 14.54% decline, so the cause remains unclear without additional market context or company information.

Enveric Biosciences is a clinical-stage biopharmaceutical company focused on psychedelic-derived therapies, a sector prone to significant volatility driven by clinical trial outcomes, regulatory developments, and shifts in investor sentiment toward novel psychiatric treatments. The absence of news headlines in the last two days suggests the sell-off may have been triggered by a non-news event such as technical selling, sector rotation, short covering reversal, or delayed market reaction to information released outside the 48-hour window. Biotech stocks of this stage typically respond sharply to clinical data, FDA communications, financing announcements, or changes in regulatory posture toward psychedelic compounds. Without specific headlines, it is impossible to pinpoint which category of catalyst drove today's move.

CLIK

Click Holdings LimitedConsumer Cyclical

$2.37−$0.40

-14.4%

NASDAQ · Mkt cap $12 M

No headlines were reported for CLIK in the last 48 hours, so the 14.44% single-day drop likely stems from an unannounced company event, market-wide sector pressure, technical selling, or delayed news dissemination.

The absence of any news coverage in the 48 hours surrounding a 14.44% intraday decline makes direct causation difficult to establish. For a micro-cap or illiquid security like CLIK, such moves can be triggered by several broad categories: an unannounced earnings miss or operational setback that has not yet been widely reported; sector-wide headwinds affecting the broader market or CLIK's industry vertical; technical factors such as stop-loss cascades or forced liquidations; or simply delayed financial news that will surface later. Without access to real-time filings, insider activity, or sector-specific alerts beyond the Yahoo Finance RSS feed provided, pinpointing the exact catalyst is not possible from the evidence at hand.

SPTX

Seaport Therapeutics, Inc. Common StockHealthcare

$17.00−$2.84

-14.3%

NASDAQ · Mkt cap $1.3 B

SPTX fell 14.31% on May 4th following a 10.2% gain the prior day; no specific negative catalyst is disclosed in available headlines, suggesting either profit-taking after the recent rally or an undisclosed development.

The most recent headline references a valuation assessment triggered by SPTX's 10.2% one-day move on an unspecified prior date that left it at $19.84, but provides no details about what caused that initial move or what subsequently prompted today's 14.31% decline. The headline appears to be commentary on the volatility itself rather than announcement of a specific corporate event (earnings, FDA decision, clinical trial result, financing, or guidance change). This pattern—a sharp up move followed by a sharper down move within 48 hours—is consistent with either profit-taking by short-term traders, short-covering reversal, or emergence of negative information not yet reflected in the provided news feed. Without disclosed catalysts, the decline likely reflects either technical momentum reversal or company-specific news not captured in the available headlines.

IPEXR

Inflection Point Acquisition Corp. V

$0.60−$0.10

-14.3%

NASDAQ

No news headlines were found in the last 48 hours to explain IPEXR's 14.29% decline, so the drop likely reflects either technical selling pressure, a delayed market reaction to an earlier announcement, or routine volatility in blank-check company securities.

IPEXR is a SPAC (special purpose acquisition company), which are inherently volatile securities with limited underlying business operations until a merger closes. The absence of any news in the past 48 hours makes it impossible to identify a specific corporate catalyst. For SPACs, price declines often stem from a combination of factors including redemption pressure ahead of a shareholder vote, delays or setbacks in announced merger negotiations, broader market weakness in the SPAC sector, or retail investor rotation out of blank-check stocks. The stock's position as the 46th biggest loser suggests it was not an isolated move but part of broader sector weakness or market conditions. Without access to recent filings, merger deal status, or redemption announcements, only generic mechanical or sentiment-based explanations are available.

WTO

UTime LimitedTechnology

$1.29−$0.21

-14.0%

STEX

Streamex Corp.Financial Services

$1.02−$0.17

-14.0%

RDAC

Rising Dragon Acquisition Corp.Financial Services

$8.01−$1.28

-13.8%

NASDAQ · Mkt cap $35 M

No news headlines were found in the last 48 hours to explain RDAC's 13.78% drop, so the driver remains unclear without additional reporting.

Rising Dragon Acquisition Corp. is a SPAC (special purpose acquisition company), a structure prone to sharp price swings driven by deal rumors, redemption pressure, or shifts in merger expectations rather than traditional earnings or operational catalysts. The absence of news in the provided headlines does not mean no catalyst exists; SPAC-focused investors and trading desks often react to private information about deal status, shareholder redemption rates, or timeline delays that may not yet appear in broad financial media. The 13.78% single-day drop could reflect a deal setback, increased redemption risk, sponsor disputes, or simple de-SPAC momentum reversal. Without documented headlines tying the move to a specific event, the cause remains inference rather than fact.

SNBR

Sleep Number CorporationConsumer Cyclical

$2.68−$0.43

-13.7%

NASDAQ · Mkt cap $611 K

No news headlines were found in the last 48 hours, so the 13.71% decline in Sleep Number cannot be directly attributed to a disclosed event. The drop likely reflects either broader market weakness, technical selling, or undisclosed company developments.

Sleep Number is a furniture retailer heavily dependent on consumer discretionary spending and interest rates. In the absence of news, a 13.71% single-day decline in a company ranked 50th biggest loser suggests either company-specific developments not yet reported by Yahoo Finance, or participation in a broader sector or market selloff. Furniture and bedding retailers are cyclical and sensitive to consumer confidence, housing starts, and financing availability. Without confirmed headlines, potential explanatory categories include disappointing same-store sales trends, weak guidance ahead of earnings, dividend or capital structure changes, or macroeconomic headwinds affecting discretionary retail. The lack of reported news does not rule out that internal news or rumors circulated through other channels before official disclosure.